Covid-19: Lilly’s Antibody Cocktail Down But Not Yet Out
LY-CoV555 shows some promise for patients recently diagnosed with Covid-19 Eli Lilly’s...
Read MoreNov 2, 2020
LY-CoV555 shows some promise for patients recently diagnosed with Covid-19 Eli Lilly’s...
Read MoreNov 2, 2020
There have been many studies that have been conducted so far in order to understand the...
Read MoreOct 29, 2020
Health officials in San Francisco and Alameda counties have cut ties with Verily’s state-funded COVID testing sites amid concerns about data collection and privacy.
Read MoreOct 28, 2020
Study supports routine serial TTE in these patients Nearly two-thirds of Covid-19 patients who...
Read MoreOct 28, 2020
Prevalence of COPD lower than expected in one study The prevalence of chronic obstructive...
Read MoreOct 28, 2020
Meanwhile, two conflicting studies leave question of antibody response post-Covid infection up in...
Read MoreOct 27, 2020
There has been almost a year since the outbreak of the novel coronavirus and hence, till now there...
Read MoreOct 27, 2020
There have been various studies that have been conducted so far in order to measure the subset of...
Read MoreOct 27, 2020
MONDAY, Oct. 26, 2020 (HealthDay News) — Sex, age, and severity of disease can predict...
Read MoreOct 27, 2020
MONDAY, Oct. 26, 2020 (HealthDay News) — The COVID-19 pandemic may have negatively impacted...
Read MoreOct 27, 2020
MONDAY, Oct. 26, 2020 (HealthDay News) — Drugmakers AstraZeneca and Johnson & Johnson...
Read MoreOct 27, 2020
Racial disparities persist after controlling for age, sex, socioeconomic status, or comorbidities...
Read MoreOct 26, 2020
FRIDAY, Oct. 23, 2020 (HealthDay News) — For patients with moderate COVID-19, convalescent...
Read MoreOct 26, 2020
FRIDAY, Oct. 23, 2020 (HealthDay News) — For patients with psoriasis, survival from COVID-19...
Read MoreOct 26, 2020
FRIDAY, Oct. 23, 2020 (HealthDay News) — Tocilizumab may be beneficial for adults with...
Read MoreOct 26, 2020
FRIDAY, Oct. 23, 2020 (HealthDay News) — At a meeting of the U.S. Food and Drug...
Read MoreOct 26, 2020
Much-touted antiviral drug gains full approval following EUA WASHINGTON — The FDA granted full...
Read MoreOct 26, 2020
RCT findings again at odds with observational studies Hospitalized Covid-19 patients treated with...
Read MoreOct 26, 2020
VHA Covid-19 patients at higher risk for 17 respiratory/non-respiratory complications Patients...
Read MoreOct 26, 2020
Glimmers of hope are beginning to appear in the fight against the coronavirus, such as a decreasing death rate. But there’s not-so-good news, too, including a push for “herd immunity,” which could result in millions more deaths. Meanwhile, the Trump administration doubles down on work requirements for Medicaid. Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Read More